Nurses demand voice in physician associate review | Nursing Times
Learn about why nurses are calling for greater involvement in the ongoing review into physician associates.
Related Articles
Perjeta Regimen Improves Survival in HER2+ Early-Stage Breast Cancer
Treatment with Perjeta, Herceptin and chemotherapy post-surgery led to a significant overall survival benefit in HER2-positive early-stage breast cancer.
When a Thoughtless Mammogram Reminder Reopened a Deep Cancer Wound
A thoughtless birthday mammogram reminder underscored how the healthcare system ignored my reality of living with metastatic breast cancer.
Tagrisso Therapy Elicits Wave of New Therapeutic Approaches in NSCLC
Dr. Suresh Ramalingam discussed how the LAURA findings support the role of Tagrisso as a backbone therapy across multiple settings in EGFR-mutated NSCLC.
Share Your Story | Cancer Stories | CURE
Your stories help CURE achieve its mission of combining science and humanity to make cancer understandable for everyone. Have a story that you’d like to…
An Unexpected Lesson to Live Intentionally
In the latest installment of her leadership series, Barbara Schmidtman delves into the unexpected gift that can come from illness: stillness and time for reflection.
Cancer Didn’t Break Me; It Revealed My Strength
I’m a single mom with chronic lymphocytic leukemia sharing how cancer tested me but revealed my resilience, hardship and the power of speaking up.
Understanding the Unique Task of Treating Older Patients With Breast Cancer
Dr. Hyman B. Muss discusses the unique challenges that older patients with breast cancer face during and after treatment for their disease.
Nurses demand voice in physician associate review | Nursing Times
Learn about why nurses are calling for greater involvement in the ongoing review into physician associates.
Caring for Nurses Strengthens Economies – Evidence-Based Nursing blog
To mark International Nurses Day 2025 on 12th May this blog written by our Editor-in-Chief, Dr Alison Twycross (@alitwy) reflects on how caring for nurses…
IHC Testing Aims to Expand Personalized Treatment in Lung Cancer
Investigators are using MET immunohistochemistry testing and FDA-approved profiling tools to personalize care and address unmet needs in NSCLC treatment.